59 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33970224 | CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors. | 2022 May 6 | 2 |
2 | 35506379 | Abnormal Cyclic Nucleotide Signaling at the Outer Mitochondrial Membrane In Sympathetic Neurons During the Early Stages of Hypertension. | 2022 Jul | 1 |
3 | 30835157 | Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice. | 2019 May | 1 |
4 | 31100470 | PDE2 regulates membrane potential, respiration and permeability transition of rodent subsarcolemmal cardiac mitochondria. | 2019 Jul | 4 |
5 | 31121256 | Effect of phosphodiesterase (1B, 2A, 9A and 10A) inhibitors on central nervous system cyclic nucleotide levels in rats and mice. | 2019 Oct | 1 |
6 | 31253692 | Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the Rat. | 2019 Sep | 7 |
7 | 31521738 | TAK-915, a phosphodiesterase 2A inhibitor, ameliorates the cognitive impairment associated with aging in rodent models. | 2019 Dec 30 | 2 |
8 | 29440309 | Phosphodiesterase 2A Inhibitor TAK-915 Ameliorates Cognitive Impairments and Social Withdrawal in N-Methyl-d-Aspartate Receptor Antagonist-Induced Rat Models of Schizophrenia. | 2018 Apr | 2 |
9 | 29720569 | Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity. | 2018 May 3 | 4 |
10 | 30051530 | 17β-Estradiol reduces mitochondrial cAMP content and cytochrome oxidase activity in a phosphodiesterase 2-dependent manner. | 2018 Oct | 1 |
11 | 30651902 | Low-Concentration Oxygen/Ozone Treatment Attenuated Radiculitis and Mechanical Allodynia via PDE2A-cAMP/cGMP-NF-κB/p65 Signaling in Chronic Radiculitis Rats. | 2018 | 1 |
12 | 28283839 | Selective phosphodiesterase-2A inhibitor alleviates radicular inflammation and mechanical allodynia in non-compressive lumbar disc herniation rats. | 2017 Jul | 1 |
13 | 25916722 | Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons. | 2015 Jul | 1 |
14 | 25939307 | Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities. | 2015 Aug | 1 |
15 | 26178667 | Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus. | 2015 Oct | 2 |
16 | 24184653 | Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain. | 2014 Feb | 2 |
17 | 24424715 | Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium. | 2014 May | 11 |
18 | 24531807 | PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways. | 2014 Apr 15 | 5 |
19 | 24837549 | Phosphodiesterase 2 negatively regulates adenosine-induced transcription of the tyrosine hydroxylase gene in PC12 rat pheochromocytoma cells. | 2014 Jul 5 | 4 |
20 | 24899690 | Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension. | 2014 Aug 5 | 2 |
21 | 23597790 | Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacy. | 2013 Jun 1 | 2 |
22 | 23810893 | Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes. | 2013 Oct 22 | 5 |
23 | 21330599 | cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes. | 2011 Apr 15 | 7 |
24 | 21653225 | cGMP phosphodiesterase inhibition improves the vascular and metabolic actions of insulin in skeletal muscle. | 2011 Aug | 2 |
25 | 20139324 | Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases. | 2010 Apr | 1 |
26 | 20196107 | Expression and function of phosphodiesterases in nitrofen-induced congenital diaphragmatic hernia in rats. | 2010 Apr | 2 |
27 | 20213343 | Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease. | 2010 Jun | 2 |
28 | 21151982 | Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II. | 2010 Dec 3 | 5 |
29 | 19632989 | Dual acylation of PDE2A splice variant 3: targeting to synaptic membranes. | 2009 Sep 18 | 2 |
30 | 18499090 | The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging. | 2008 Jun 24 | 1 |
31 | 18501878 | NO-mediated cGMP synthesis in cultured cholinergic neurons from the basal forebrain of the fetal rat. | 2008 Jun 27 | 2 |
32 | 18655195 | In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats. | 2008 Nov 15 | 7 |
33 | 18684888 | cGMP decreases surface NKCC2 levels in the thick ascending limb: role of phosphodiesterase 2 (PDE2). | 2008 Oct | 5 |
34 | 18957291 | Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion. | 2008 Dec 14 | 3 |
35 | 17141339 | Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages. | 2007 Feb | 4 |
36 | 17302738 | Changes in purine specificity in tandem GAF chimeras from cyanobacterial cyaB1 adenylate cyclase and rat phosphodiesterase 2. | 2007 Mar | 3 |
37 | 17407767 | Changes in NMDA receptor-induced cyclic nucleotide synthesis regulate the age-dependent increase in PDE4A expression in primary cortical cultures. | 2007 May 29 | 1 |
38 | 16621444 | ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord. | 2006 Jun | 1 |
39 | 15599707 | Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin. | 2004 Dec | 1 |
40 | 12834273 | cGMP-phosphodiesterase activity is up-regulated in response to pressure overload of rat ventricles. | 2003 May | 1 |
41 | 12003819 | Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population. | 2002 Jun | 3 |
42 | 12065724 | Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus. | 2002 Jul | 3 |
43 | 12107056 | Attenuation of cAMP accumulation in adult rat cardiac fibroblasts by IL-1beta and NO: role of cGMP-stimulated PDE2. | 2002 Aug | 2 |
44 | 12221013 | Changes in phosphodiesterase activity in the developing rat submandibular gland. | 2002 Aug | 3 |
45 | 12358727 | Kinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP. | 2002 Oct | 3 |
46 | 11150485 | The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. | 2001 Jan 12 | 3 |
47 | 11181844 | Nerve growth factor inhibits PC12 cell PDE 2 phosphodiesterase activity and increases PDE 2 binding to phosphoproteins. | 2001 Feb | 1 |
48 | 11532906 | Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. | 2001 Aug 31 | 1 |
49 | 10704943 | Inactivation of atrial natriuretic factor-stimulated cyclic guanosine 3',5'-monophosphate (cGMP) in UMR-106 osteoblast-like cells. | 2000 May 1 | 4 |
50 | 10913949 | Role of phosphodiesterase and protein kinase G on nitric oxide-induced inhibition of prolactin release from the rat anterior pituitary. | 2000 Aug | 2 |